Overview of Bleeding Rate Improvement with Impella® IMP-1041...

With Impella support in high-risk PCI, overall incidence of post-procedural AKI is significantly re...

Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...

Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study...

Anticoagulation Therapy with Impella® Heparin Infusion...

Using a defined cardiogenic shock best practices protocol derived from real-world data for...

The Impella CP is approved for use in high-risk percutaneous coronary intervention and cardiogenic shock and are proven to unlo...

Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® hea...

New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients...

Committed to improving outcomes in Cardiogenic Shock and Protected PCI through excellence in education....

Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device  from the...

A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...

Use this FDA-approved checklist to guide treatment decisions and determine if the Impella RP is right for your patients....

This sheath enables reaccess to the artery for the duration of Impella support with up to an 0.035” guidewire. The additional...

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

Dr. Michael P. Flaherty's TCT 2018 presentation on Renal Effects of Impella support during Protected PCI....

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) da...

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

For patients in post cardiotomy cardiogenic shock (PCCS), the Impella LD can assist in the efforts to successfully unload the l...

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP h...

Impella 2.5/Impella CP/Impella 5.0/Impella LD/Impella RP Heart Pumps - Quick Reference and Troubleshooting Guide For AIC Softwa...

Download the WVU Heart & Vascular Institute Complete Revascularization of Complex and High Risk Coronary Artery Disease Alg...

Dr. Tanveer Rab of Emory University joins Dr. Cathy Jeon to discuss a case of an 80 year old male with a low ejection fraction...

The use of standardized protocols has been associated with improvement in outcomes for people in...

This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Ci...

Download INOVA Heart and Vascular Institute’s Protected PCI algorithm, which begins with a heart team evaluation of high risk...

The Impella® Program Protocol and Tools Provides Resources on Impella Best Practices Including:Data-driven proto...

On March 23, 2015, the Impella 2.5™ received PMA approval from the U.S. FDA* and on December 2, 2016 the Impella CP® r...

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  ...

Abiomed has observed that when clinicians encounter an unreliable differential pressure sensor while a patient is being support...

Recommendation for maintaining initial insertion site angle with the Impella 2.5 and Impella CP heart pumps...

Animation of Impella RP...

Reference card for determining which patients benefit from Impella and the hemodynamic effects of Impella support....